Delivery Order SPE2DB22D2009-SPE2DB24FL8SL
Award Date
3/15/24
Potential Completion Date
3/18/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $5,922.24 to supply DESCOVY 200-25 MG TABLET pharmaceutical products. This order has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $19,407.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET medication. The $6,023.95 contract, which has a performance period through March 29, 2024, is not associated with any set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S. The $2,589.45 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3012|SPE2DX24F8KZ8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of DESCOVY 200-25 MG TABLET medication. The $29,665.90 contract has a performance period through March 21, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) with a $999,999,999.00 ceiling...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,634.07 firm fixed price delivery order contract for the provision of DESCOVY 200-25 MG TABLET medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $11,113.25 and a period of performance through April 15, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D3016|SPE2DB24FARV8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $20,541.71. The contract, which does not have a set-aside designation, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite...
The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $20,919.09, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $6,034.24 and a completion date of February 21, 2024. This delivery order contract is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...